Zylö accepted into NYU’s exclusive Endless Frontier Labs mentorship program
Zylö Therapeutics has been selected to join the Endless Frontier Labs (EFL) 2023-2024 cohort alongside 77 other startups. Over 1,400 companies applied, including over 350 life science companies, with only 26 chosen in each of the three tracks: life sciences, deep-tech, and digital tech. Over the next nine months, EFL mentors and NYU Stern MBA students will work with Zylö’s executive team to fine-tune Zylö strategies, craft an improved pitch deck, and set/achieve value-added objectives. Read more >>